See All Slides - tctmd.com

Slides

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Presenter: Chirag Mehta

March 05, 2024

Presentation THT Abstracts 2024

Sex and race differences in objective measures of frailty, provider assessed frailty, and associated outcomes: an Intermacs registry analysis

Presenter: Rebecca Steinberg

March 05, 2024

Presentation THT Abstracts 2024

Real-world outcomes of patients implanted with a pulmonary artery pressure sensor: Insights from the HF2 Registry

Presenter: Elizabeth Volz

March 05, 2024

Presentation THT Abstracts 2024

Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures

Presenter: Andrew Sauer

March 05, 2024

Presentation THT Abstracts 2024

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides

Presenter: Andrew Sauer

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Presenter: Justin Cortez

March 05, 2024

Presentation THT Abstracts 2024

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Presenter: Jennifer Cowger

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Advertisement

Slides

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Sex and race differences in objective measures of frailty, provider assessed frailty, and associated outcomes: an Intermacs registry analysis

Real-world outcomes of patients implanted with a pulmonary artery pressure sensor: Insights from the HF2 Registry

Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content